Our data suggested that through inhibiting the expression of Bcl-2, Mcl-1 and x-linked inhibitor of apoptosis (xIAP), Oridonin synergistically enhanced the anti-HCC activity of JQ1 through mitochondrial pathway. This evidence concerns the gene XIAP and hepatocellular carcinoma.